首页> 美国卫生研究院文献>Molecules >Leptadenia reticulata (Retz.) Wight Arn. (Jivanti): Botanical Agronomical Phytochemical Pharmacological and Biotechnological Aspects
【2h】

Leptadenia reticulata (Retz.) Wight Arn. (Jivanti): Botanical Agronomical Phytochemical Pharmacological and Biotechnological Aspects

机译:Leptadenia reticulata(Retz。)Wight&Arn。 (Jivanti):植物学农艺学植物化学药理学和生物技术方面

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Leptadenia reticulata (Retz.) Wight & Arn. (Apocynaceae), is a traditional medicinal plant species widely used to treat various ailments such as tuberculosis, hematopoiesis, emaciation, cough, dyspnea, fever, burning sensation, night blindness, cancer, and dysentery. In Ayurveda, it is known for its revitalizing, rejuvenating, and lactogenic properties. This plant is one of the major ingredients in many commercial herbal formulations, including Speman, Envirocare, Calshakti, Antisept, and Chyawanprash. The therapeutic potential of this herb is because of the presence of diverse bioactive compounds such as α-amyrin, β-amyrin, ferulic acid, luteolin, diosmetin, rutin, β-sitosterol, stigmasterol, hentricontanol, a triterpene alcohol simiarenol, apigenin, reticulin, deniculatin, and leptaculatin. However, most biological studies on L. reticulata are restricted to crude extracts, and many biologically active compounds are yet to be identified in order to base the traditional uses of L. reticulata on evidence-based data. At present, L. reticulata is a threatened endangered plant because of overexploitation, unscientific harvesting, and habitat loss. The increased demand from pharmaceutical, nutraceutical, and veterinary industries has prompted its large-scale propagation. However, its commercial cultivation is hampered because of the non-availability of genuine planting material and the lack of knowledge about its agronomical practices. In this regard, micropropagation techniques will be useful to obtain true-to-type L. reticulata planting materials from an elite germplasm to meet the current demand. Adopting other biotechnological approaches such as synthetic seed technology, cryopreservation, cell culture, and genetic transformation can help conservation as well as increased metabolite production from L. reticulata. The present review summarizes scientific information on the botanical, agronomical, phytochemical, pharmacological, and biotechnological aspects of L. reticulata. This comprehensive information will certainly allow better utilization of this industrially important herb towards the discovery of lead drug molecules.
机译:Leptadenia reticulata(Retz。)Wight&Arn。 (夹竹桃科)是一种传统的药用植物,广泛用于治疗各种疾病,例如结核,造血,消瘦,咳嗽,呼吸困难,发烧,烧灼感,夜盲症,癌症和痢疾。在阿育吠陀,它以其振兴,嫩肤和生乳特性而闻名。该植物是许多商业草药配方中的主要成分之一,包括Speman,Envirocare,Calshakti,Antisept和Chyawanprash。这种草药的治疗潜力是因为存在多种生物活性化合物,例如α-amyrin,β-amyrin,阿魏酸,木犀草素,薯os皂素,芦丁,β-谷甾醇,豆甾醇,七氢三醇,三萜醇simiarenol,芹菜素,网状蛋白,地尼古丁和瘦素。然而,大多数关于网状乳杆菌的生物学研究仅限于粗提物,并且尚未确定许多生物活性化合物,以使网状乳杆菌的传统用途基于循证数据。目前,由于过度开发,不科学的收割和栖息地的丧失,网状乳杆菌是一种濒临灭绝的濒危植物。制药,营养保健和兽医行业的需求增加促使其大规模传播。但是,由于无法获得真正的种植材料以及缺乏对其农艺实践的了解,其商业化种植受到了阻碍。在这方面,微繁殖技术将可用于从优良种质中获得真正类型的网纹芒草种植材料,以满足当前的需求。采用其他生物技术方法,例如合成种子技术,冷冻保存,细胞培养和基因转化,可以帮助保存以及增加网状芒草的代谢产物产生。本综述总结了有关网纹乳酸杆菌的植物学,农艺学,植物化学,药理学和生物技术方面的科学信息。这些全面的信息肯定会更好地利用这种工业上重要的草药来发现先导药物分子。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号